{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:22:30Z","timestamp":1778786550502,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.cca.2013.04.016","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T20:04:57Z","timestamp":1366920297000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Development and validation of a sensitive and robust LC\u2013MS\/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma"],"prefix":"10.1016","volume":"423","author":[{"given":"Xin","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.04.016_bb0005","first-page":"34","article-title":"Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients","volume":"4","author":"Peuskens","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.cca.2013.04.016_bb0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4088\/JCP.v68n0603","article-title":"Study 132 investigators, efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Kahn","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.cca.2013.04.016_bb0015","first-page":"11","article-title":"The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study","volume":"41","author":"Lindenmayer","year":"2008","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.cca.2013.04.016_bb0020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1185\/030079905X46340","article-title":"Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies","volume":"21","author":"Vieta","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cca.2013.04.016_bb0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania","volume":"24","author":"Yatham","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.cca.2013.04.016_bb0030","first-page":"184","article-title":"Effectiveness of the extended-release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania","volume":"11","author":"Cutler","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.cca.2013.04.016_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00023210-200418030-00004","article-title":"Quetiapine: a review of its use in the management of schizophrenia","volume":"18","author":"Cheer","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cca.2013.04.016_bb0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine: an atypical antipsychotic","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cca.2013.04.016_bb0045","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/sj.npp.1301646","article-title":"N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1a agonist, as a putative mediator of quetiapine's antidepressant acitivity","volume":"33","author":"Jensen","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cca.2013.04.016_bb0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jpsychires.2010.02.004","article-title":"Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine","volume":"44","author":"Nikisch","year":"2010","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.cca.2013.04.016_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0731-7085(99)00036-9","article-title":"Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection","volume":"20","author":"Davis","year":"1999","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.04.016_bb0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0731-7085(02)00395-3","article-title":"HPLC analysis of the novel antipsychotic drug quetiapine in human plasma","volume":"30","author":"Mandrioli","year":"2002","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.04.016_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0378-4347(92)80473-4","article-title":"Determination of an antipsychotic agent (ICI 204, 636) and its 7-hydroxy metabolite in human plasma by high-performance liquid chromatography and gas chromatography\u2013mass spectrometry","volume":"573","author":"Pullen","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cca.2013.04.016_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpba.2007.03.034","article-title":"Validated HPLC\u2013MS\/MS method for determination of quetiapine in human plasma","volume":"44","author":"Barrett","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.04.016_bb0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jat\/28.6.443","article-title":"A liquid chromatographic-electrospray\u2013tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism","volume":"28","author":"Lin","year":"2004","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cca.2013.04.016_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/chromsci\/bms001","article-title":"Validated LC\u2013MS\u2013MS method for the determination of quetiapine in human plasma: application to a pharmacokinetic study","volume":"50","author":"Pan","year":"2012","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.cca.2013.04.016_bb0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/bmc.1012","article-title":"Sensitive liquid chromatography tandem mass spectrometry method for the quantification of quetiapine in plasma","volume":"22","author":"Nirogi","year":"2008","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.cca.2013.04.016_bb0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jchromb.2003.11.037","article-title":"Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry","volume":"802","author":"Zhou","year":"2004","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.cca.2013.04.016_bb0095","first-page":"110","article-title":"Simultaneous determination of quetiapine and 3 metabolites in human plasma by high-performance liquid chromatography electrospray ionization mass spectrometry","volume":"25","author":"Li","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.cca.2013.04.016_bb0100","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1365\/s10337-009-1353-z","article-title":"Quantification of quetiapine in human plasma by LC\u2013MS\u2013MS","volume":"70","author":"Kundlik","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.cca.2013.04.016_bb0105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jpba.2009.11.018","article-title":"Development and validation of an LC\u2013MS\/MS method for the determination of quetiapine and four related metabolites in human plasma","volume":"51","author":"Davisa","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.04.016_bb0110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/bmc.2672","article-title":"Measurement of quetiapine and four quetiapine metabolites in human plasma by LC\u2013MS\/MS","volume":"26","author":"Fisher","year":"2012","journal-title":"Biomed Chromatogr"},{"issue":"7","key":"10.1016\/j.cca.2013.04.016_bb0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1373\/49.7.1041","article-title":"Ion suppression in mass spectrometry","volume":"49","author":"Annesley","year":"2003","journal-title":"Clin Chem"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113001721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113001721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T10:59:16Z","timestamp":1539687556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113001721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":23,"alternative-id":["S0009898113001721"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.04.016","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a sensitive and robust LC\u2013MS\/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}